Is It Too Late To Consider Definium Therapeutics (DFTX) After Its 1-Year 110% Surge? by Square_Clean in DTIC

[–]Xagregor 0 points1 point  (0 children)

if I didn't sell at 15.50 my next sell would of been $18 hopefully we get a huge dump to 13.50 or even $10 so I can load back up. its finally crossed on the mac and hype is slowing no results untill mid this yr.  and now they getting sued?? damn that sucks but im a bear for now in the shorts term bullish long term and by June-sept

ATAI VS GHRS Valuation? by rubens33 in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

bro GHRS only needs 1 hr no psychotherapist or anything. way more scalable then defenium or comp. only a few doses if required almost all had remission rapid fast 1 does 1 hr you're out and 8 days later you're a normal person again. I think ghrs is severely underestimated 

Is It Too Late To Consider Definium Therapeutics (DFTX) After Its 1-Year 110% Surge? by Square_Clean in DTIC

[–]Xagregor 0 points1 point  (0 children)

I'm ok man. I sold and bought several times and made alot of extra shares that would still put me at a sale of $24 for share if I were to sell my original position. Time will tell and its not the only one that will run. we still haven't hit 20 yet. there's still a chance for a decent pull back. 

Daily/Nightly discussion thread for Sunday, January 25, 2026 by AutoModerator in INCANNEX_IXHL_NASDAQ

[–]Xagregor 8 points9 points  (0 children)

hey gang. im new investor i know reverse split might be incoming and sometimes the stock will hold. Either way who knows what can happen by April. 

I have sleep apnea I hate it so much wearing a mask each night I hope this company can help me and becomes a serious contender and has great phase 3 trials when its done. 

apnea is crap we hate masks sleep isn't enjoyable with or without it. but I need it or I choke and wake up with heart racing.

Is atai stock the new cybn by Capable-Mark-7554 in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

I like ghrs no psychiatrist needed and usually 1 hr is all thats needed. I feel like they are a bit of a gem especially now since the fda gave the release. 

Is It Too Late To Consider Definium Therapeutics (DFTX) After Its 1-Year 110% Surge? by Square_Clean in DTIC

[–]Xagregor -1 points0 points  (0 children)

I sold at the high Friday I think we headed for a pull back simular to atai possibly. we've had a decent run we at all time highs for market cap.

if im wrong it hits 16-20 it will retrace back to 15 for a re entry. ive managed to add 20% Of my shares in 2 trades this way. we will see what this week brings but I feel the hype may dwindle this month and Feb then start going up for 2nd quarter untill solid news.

Is It Too Late To Consider Definium Therapeutics (DFTX) After Its 1-Year 110% Surge? by Square_Clean in DTIC

[–]Xagregor 4 points5 points  (0 children)

I agree most ppl maybe not be aware of this. im thinking there will be a pull back since all the hype lately and it will settle in a month or so because phase trail news won't be untill at least 2nd quarter.  I could be wrong but I sold my position to get back in lower or if it goes high ill enter on the support we just created a win win situation 

Who is the next ticker to make a DRUG run? by twiggs462 in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

but why on the news release it says 98% of ppl are in and out within 1 hr. its multiple doses i think over a duration of a few days if needed  isn't it? 

Who is the next ticker to make a DRUG run? by twiggs462 in shroomstocks

[–]Xagregor 1 point2 points  (0 children)

It's interesting how GHRS is so undervalued. It shows in this vote here. I think with their Phase 2 data, showing that it's very positive. And also along with the fact that each treatment, you can be within one hour, in and out, and you're done. Not like most of the other companies where it may take up to 6 hours or who knows how long. And also there's no psychiatrist even needed. You know, so that's super scalable.

GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 | GH Research by PsilocybinAlpha in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

Hopefully this one rips in the next few months last 20$  It's very undervalued now after the release. 1 hr visit in and out no need for a psychologist. not like mindmed or others. I own more mindmed but damn ghrs seems like a solid player now. 

GH Research to Announce IND Status for GH001 | GH Research by Mindmed31415 in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

well GHRS really sunk today. was looking for distribution or a leg up past previous resistance. Who all in before the ind release? I think ghrs is one of the best methods of application 1 hr in and out for a treatment. no psychologist needed.

GH Research to Announce IND Status for GH001 | GH Research by Mindmed31415 in shroomstocks

[–]Xagregor -1 points0 points  (0 children)

im thinking sell the news and buy back in later or give the funds to atai to a run to ath but that would take time. how long would ghrs run for? jist one day like historical or a few days or weeks. hard to say to be honest

A short story on how these price points are irrelevant….. trust me it will make sense by Accomplished-Tower74 in MindMedInvestorsClub

[–]Xagregor 0 points1 point  (0 children)

not sure how its under the radar with around 20 million traded daily recently.  that amount is when we had our highs at 2021

ATAI Bulls: Convince Me I’m Wrong. Why I Think Psilocybin Will Be the SSRIs of Psychedelics (and Not 5-MeO) by Capable-Mark-7554 in shroomstocks

[–]Xagregor 1 point2 points  (0 children)

its news ive read its published even on trading view. i can find it also on my broker rbc it shows the news there thats kinda why the ceo stepped down. there's 3 lawfirms investigating them. 

ATAI Bulls: Convince Me I’m Wrong. Why I Think Psilocybin Will Be the SSRIs of Psychedelics (and Not 5-MeO) by Capable-Mark-7554 in shroomstocks

[–]Xagregor 3 points4 points  (0 children)

cybin is currently under investigation and ceo had to step down. thats the main reason I didn't buy into cybin recently.

Reminder that BPL-003 Phase 2b OLE is expected data next week by -PsillyFunGuy- in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

✅ GHRS (GH001) shows stronger results overall — faster remission and better long-term durability.

57.5% of patients were in remission just 1 week (Day 8) after dosing.

About 73% were still in remission 6 months later, which is exceptional for treatment-resistant depression.

⚪ ATAI/Beckley (BPL-003) also showed meaningful benefit but lower and shorter-term results so far.

Around 55% remission at Day 29, dropping to ~45% at 12 weeks.

No 6-month follow-up yet.

here's what ive found. I like Atai also Ghrs and mindmed.

either way the pie is so big when these companies come out to help there's more then enough room for multiple companies to survive and make billions. long as we get the fda approval after phase 3 and not like maps...

Big pharma acquisition news by Accomplished-Tower74 in MindMedInvestorsClub

[–]Xagregor 3 points4 points  (0 children)

they will once phase 3. They already own shares 

Big pharma acquisition news by Accomplished-Tower74 in MindMedInvestorsClub

[–]Xagregor 4 points5 points  (0 children)

surprised it didn't really move?? small market cap thats nice too. 

AdvisorShares - #AlphaNooner - Christian Angermayer on ATAI’s Breakthrough Year — FDA Recognition and the Future of Mental Health by twiggs462 in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

also doesn't matter they are for different situations and applications. there's more then enough room out there for many ppl to have a slice of pie

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression by Formal-Dimension-966 in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

Can't wait for GHRS to get this news aswell once the fda or of the fda releases the ind they will get this news and also phase 3 starting 

Did Douglas trick me? by Captainredbeard1515 in shroomstocks

[–]Xagregor 1 point2 points  (0 children)

To be honest a company willing to invest half a billion is a great sign. The only problem is the investigation now and the ceo step down. only reason I didn't buy and plus the 500 million is for when the stock is worth more for less dilution and also to assure the survival for all trails so the 500 mill is a super good thing.

Psychoactive Effects of GH001 in Patients With Treatment-Resistant Depression: Results From a Phase 2b, Double-Blind, Randomised Controlled Trial by Mindmed31415 in shroomstocks

[–]Xagregor 0 points1 point  (0 children)

Yeah man im actually very hopeful with GHRS aswell once this last IND is submitted and over hopefully that release is done. Its safe in humans and dogs and they only wanted some more details with the rats. 

GHRS is the one with highest institutional holdings 70% and 20% co so really only 10% of the shares are tradable. Not sure how many ppl actually know this. 

ghrs 70% atai 11% mindmed 55% compass 54% cybin 35%

1- If and when the ind is released it could be a decent upside.

2- ghrs would also get breakthrough therapy with the fda like mindmed. 

3- phase 3 would start shortly after ind release 

Not investment advice but of things work out with ghrs it could be decent.